If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Humalog®
Humalog® U-100 (insulin lispro injection)
100 units/mLHumalog® U-200 (insulin lispro injection)
200 units/mLHumalog® MIX50/50™ (50% insulin lispro protamine suspension 50% insulin lispro injection [rDNA origin])
100 units/mLHumalog® MIX75/25™ (75% insulin lispro protamine suspension 25% insulin lispro injection [rDNA origin])
100 units/mLThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Do NOT perform dose conversion when using the IL-200 Pen.
The dose window shows the number of insulin units to be delivered and no conversion is needed.1
Therefore, a patient receiving 20 units of IL-100 and transitioning to the IL-200 Pen should dial the Pen to 20 units to administer the same 20-unit dose of insulin lispro.
Enclosed Prescribing Information
HUMALOG® (insulin lispro injection), for subcutaneous or intravenous use, Lilly
1. Humalog [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.
Glossary
IL-100 = Humalog® (insulin lispro injection) 100 units/mL
IL-200 = Humalog® (insulin lispro injection) 200 units/mL
Pen = KwikPen®
Date of Last Review: December 13, 2019
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 9am - 7pm EST